To direct the Secretary of Veterans Affairs to conduct a pilot program on the provision of naloxone to veterans and their caregivers, and for other purposes.

HR 10038 directs the Veterans Affairs (VA) Secretary to run a two-year pilot program making naloxone available at no cost and without a prescription to veterans and their VA-registered caregivers at VA pharmacies and medical facilities. The program requires providing information about VA addiction, suicide prevention, and mental health services, along with naloxone use education. The VA must report to Congress within 90 days of the pilot's end, detailing participation numbers, feasibility of expanding to family members or non-VA providers, and budget considerations for potential permanent adoption. This bill directly affects veterans and their registered caregivers by removing barriers to accessing overdose reversal medication.